CD4 and sexually transmitted disease: When the CD4 count at diagnosis in the STD setting was varied by increments of 20 cells/μL from 356 cells/μL (equal to the base case value for the ED setting) to 436 cells/μL, STD screening remained cost-saving compared with ED screening even for a difference as small as 20 cells/μL when transmission benefits were included in the analysis.